Please provide your email address to receive an email when new articles are posted on . The FDA announced it has authorized marketing of the first laser-based device for the removal of inferior vena ...

SILVER SPRING, Md., Dec. 21, 2021 /PRNewswire/ -- Today, the U.S. Food and Drug Administration authorized marketing of the first laser-based device for the removal of Inferior Vena Cava (IVC) filters.

The FDA granted breakthrough device designation to Royal Philips NV for its laser-assisted inferior vena cava (IVC) filter removal device. The Amsterdam-based company designed the device to ablate ...

Philips has scored a de novo clearance from the FDA for the first laser-based device for removing blood vessel filter implants that aim to strain out traveling blood clots before they damage the lungs ...

The US Food and Drug Administration (FDA) has cleared for marketing the Philips CavaClear Laser Sheath, the first laser-based device to facilitate removal of inferior vena cava (IVC) filters when ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window FDA approved the ...

First use of Philips' breakthrough CavaClear solution to help patients with embedded IVC filters, including an athlete suffering from a 16-year old penetrating filter Only FDA-cleared solution for ...

Cook Group is suing an underwriter at Lloyd’s of London insurance group for breach of contract, saying it failed to honor a $10 million policy against claims by patients who said they were injured by ...